Company 'knew of drug fears before withdrawal'
Evidence that the painkiller Vioxx might increase the risk of heart attacks and strokes emerged nearly four years before the drug was voluntarily withdrawn from the market, research has shown.
Vioxx, the brand name for rofecoxib, was designed to fight the pain of arthritis. It was launched in May 1999 by Merck & Co Inc. But in September 2004, Merck voluntarily pulled Vioxx following a large trial that was halted early after finding evidence linking Vioxx to a raised risk of cardiovascular events.
In November 2004, Merck's then chief executive Raymond Gilmartin testified before a US Senate finance committee that until the halted trial, there was no suggestion from research data that patients taking Vioxx were at increased risk.
Yesterday, experts from the Mount Sinai School of Medicine in New York writing in the journal Archives of Internal Medicine produced evidence of clear concerns about Vioxx from December 2000 onwards.
Actress sees off speculation about her appearance in an amazing way
Review: Despite an uphill climb to see Jake Bugg in action, his performance is notably flat
Life & Style blogs
iPhone 6 'catches on fire and burns man's leg after bending in his pocket'
The hoverboard is real, and it could give rise to hoverhouses
Drink alcohol and eat meat to improve male fertility - but cut down on coffee, studies suggest
The inventor of the Facebook 'like' button says he never made a 'dislike' button because he feared the 'unfortunate consequences'
Lynda Bellingham dead: Bowel cancer - what is it and what are the symptoms?
- 1 Renee Zellweger on plastic surgery reports: 'I'm living a fulfilling life and I'm thrilled that perhaps it shows'
- 2 Salisbury ranked seventh-best city in the world to visit in Lonely Planet’s Best in Travel 2015
- 3 Disney announces new female-led film Moana
- 4 Banksy not arrested: Internet duped by fake report claiming artist's identity revealed
- 5 Russell Brand threatened with arrest after filming outside Fox News headquarters
Competitive Salary: Randstad Education Group: We are urgently seeking an exper...
£35000 per annum: Ashdown Group: 5 month Fixed Term Contract - Telecommunicati...
£18000 per annum + competitive OTE: SThree: Progressive in Manchester is seeki...
£24000 - £28000 per annum + bonus & benefits: Ashdown Group: IT Business Syste...